Tipifarnib potentiates the antitumor effects of PI3Kα inhibition in PIK3CA- and HRAS-dysregulated HNSCC via convergent inhibition of mTOR activity https://www.biorxiv.org/content/10.1101/2023.01.17.523964v1?med=mas
Tipifarnib potentiates the antitumor effects of PI3Kα inhibition in PIK3CA- and HRAS-dysregulated HNSCC via convergent inhibition of mTOR activity https://www.biorxiv.org/content/10.1101/2023.01.17.523964v1?med=mas